Highest-materiality recent filing
Ryan Specialty boosts buyback authorization by $300M to $600M total
Board increased share repurchase program by $300M on May 21, 2026; total authorization now $600M.
Ryan Specialty Q1 revenue up 15.2%; net income $40.6M vs prior-year loss
Total revenue $795.2M (+15.2% YoY); organic growth 11.8%, down from 12.9% prior-year.
Q4 revenue $751.2M (+13.2% YoY); organic growth 6.6% vs 11.0% prior year.
Ryan Specialty Q3 revenue up 24.8% to $754.6M, organic +15.0%, net income $62.6M
Total revenue $754.6M, +24.8% YoY; organic growth 15.0% (vs 11.8% prior-year).
Ryan Specialty appoints Keogh and Mulshine as Co-Presidents; Bickham advisor
Stephen P. Keogh named Co-President and COO; Brendan M. Mulshine named Co-President and CRO.
Ryan Specialty Q2 total revenue $855.2M, +23% YoY; Adj. EPS $0.66, +13.8%; declares $0.12 dividend
Total revenue $855.2M (+23.0% YoY); organic revenue growth 7.1% decelerated from 14.2%.
Ryan Specialty board lead director Cam Findlay dies; successors named
D. Cameron Findlay, board member since 2012 and Lead Director, passed away unexpectedly in July 2025.
Ryan Specialty stockholders approve governance overhaul including Class B vote sunset by Sept 2029
Stockholders approved declassification of Board and phase-in of annual director elections; four nominees elected to three-year terms expiring 2028.
Ryan Specialty Q1 rev up 25% to $690M; GAAP net loss $4.4M; declares $0.12 dividend
Total revenue $690.2M (+25% YoY); organic growth 12.9%.
Ryan Specialty Q4 revenue up 24.5% to $663.5M; Adj. EBITDAC +36.2%; declares $0.12 dividend
Total revenue $663.5M (+24.5% YoY); organic growth 11.0% (vs 16.5% prior year).
On March 27, 2025, Ryan Specialty Holdings, Inc. (the “Company”) announced the appointment of Mr. Stephen P. Keogh to the position of Chief Operating Officer of the Company, effective May 1, 2025.
Max materiality 0.80 · Median 0.65 · Most common event earnings